Gene therapy maker UniQure to cut about 20% of workforce

Dutch gene therapy maker uniQure (UQ1.F) said on Thursday it would cut about 20% of its total workforce, or about 114 jobs, and end investments in more than half of its research and technology projects to reduce costs.